- Home
- CLDX vs IMAX Comparison
CLDX vs IMAX Comparison
Compare CLDX & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- IMAX
- Stock Information
- Founded
- CLDX N/A
- IMAX 1967
- Country
- CLDX United States
- IMAX Canada
- Employees
- CLDX N/A
- IMAX N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IMAX
- Sector
- CLDX Health Care
- IMAX
- Exchange
- CLDX Nasdaq
- IMAX Nasdaq
- Market Cap
- CLDX 1.4B
- IMAX 1.3B
- IPO Year
- CLDX 2008
- IMAX 1994
- Fundamental
- Price
- CLDX $22.08
- IMAX $28.56
- Analyst Decision
- CLDX Strong Buy
- IMAX Strong Buy
- Analyst Count
- CLDX 9
- IMAX 9
- Target Price
- CLDX $46.13
- IMAX $32.44
- AVG Volume (30 Days)
- CLDX 1.5M
- IMAX 906.3K
- Earning Date
- CLDX 08-07-2025
- IMAX 07-24-2025
- Dividend Yield
- CLDX N/A
- IMAX N/A
- EPS Growth
- CLDX N/A
- IMAX 52.36
- EPS
- CLDX N/A
- IMAX 0.60
- Revenue
- CLDX $5,790,000.00
- IMAX $362,475,000.00
- Revenue This Year
- CLDX N/A
- IMAX $16.96
- Revenue Next Year
- CLDX N/A
- IMAX $5.72
- P/E Ratio
- CLDX N/A
- IMAX $48.07
- Revenue Growth
- CLDX N/A
- IMAX 1.25
- 52 Week Low
- CLDX $14.40
- IMAX $18.76
- 52 Week High
- CLDX $47.00
- IMAX $29.66
- Technical
- Relative Strength Index (RSI)
- CLDX 47.99
- IMAX 66.38
- Support Level
- CLDX $21.34
- IMAX $25.56
- Resistance Level
- CLDX $23.27
- IMAX $29.36
- Average True Range (ATR)
- CLDX 1.54
- IMAX 0.67
- MACD
- CLDX -0.15
- IMAX 0.43
- Stochastic Oscillator
- CLDX 33.75
- IMAX 81.40
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.